Purpose: Mechanistic and observational studies support an independent increase in risk of
hypertension and abnormal glucose metabolism associated with obstructive sleep apnea …

OBJECTIVE Despite evidence of a relationship among obstructive sleep apnea (OSA),
metabolic dysregulation, and diabetes, it is uncertain whether OSA treatment can improve …

Context Systemic hypertension is prevalent among patients with obstructive sleep apnea
(OSA). Short-term studies indicate that continuous positive airway pressure (CPAP) therapy …

Obstructive sleep apnea (OSA) is characterized by repetitive partial and total collapse of the
upper airway that induces stressful arousals throughout sleep to reestablish breathing …

Study Objectives: We sought to perform a patient-level meta-analysis using the individual
patient data of the trials identified in our previous study-level meta-analysis investigating the …

Obstructive sleep apnea (OSA) is considered to be a secondary form of hypertension and in
clinical practice OSA is frequently associated with hypertension, even if proof of causality …

In the last decade, large epidemiological and prospective studies have shown an
independent association between obstructive sleep apnea (OSA) and hypertension [1–4] …

Many patients with obstructive sleep apnea (OSA), but not all, have a reduction in blood
pressure (BP) with positive airway pressure (PAP) treatment. Our objective was to determine …

Objective: Several studies have reported a small yet significant decrease in blood pressure
(BP) with continuous positive airway pressure (CPAP) application in patients with obstructive …

Background: Obstructive sleep apnea (OSA) is a major cause of secondary hypertension.
Moreover, a considerable proportion of patients with essential hypertension have OSA. OSA …